Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV
The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.
Appendix B: Panel Roster and Financial Disclosures
Last Updated: September 1, 2014; Last Reviewed: September 1, 2014
|Bhattacharya, Debika||University of California, Los Angeles||International Antiviral Society – USA||Honoraria|
|Jain, Mamta||University of Texas Southwestern Medical Center
||AbbVie||Advisory Board, Research Support|
|Boehringer Ingelheim||Advisory Board, Research Support|
|Gilead Sciences||Advisory Board, Research Support, Speaker's Bureau|
|Nunez, Marina||Wake Forest University Health Sciences
|Peters, Marion*||University of California, San Francisco||Biotron||Advisory Board|
|GReD||Spouse has relationship|
|International Antiviral Society (IAS-USA)||Advisory Board|
|Johnson & Johnson
|Thio, Chole||Johns Hopkins University
* Group lead
Note: Members were asked to disclose all relationships from 24 months prior to the updated date. The period of reporting was from September 1, 2012, through September 1, 2014.
- CDC | 2015 STD Treatment Guidelines
- HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C
- AIDSinfo Patient Materials: What is an Opportunistic Infection?
- AIDSource | HIV-Related Conditions
- AETC National HIV Curriculum
- How to Cite These Guidelines
- Adult and Adolescent OI Guidelines Archive